Clinical trials tested doses ranging from 250mcg to 1mg daily, with most protocols settling around 300-500mcg for optimal fat metabolism support
Only eCATH-2 and eCATH-3 were detected, being consistent with the observations of the first study
BPC-157 has demonstrated remarkably low toxicity with no established lethal dose, and its origin from human gastric juice suggests good biological compatibility
This delivery method is pain-free, as the short needle avoids major blood vessels
Copyright: The Author(s) About this article Cite this article LeTrilling, V.T.K., Banchenko, S., Paydar, D
It is stable in gastric acid and can be taken orally, which gives it a practical edge for gut applications